PHARMATEKET ApS: Financial statements 2022
CVR: 15183381
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMATEKET ApS (CVR 15183381) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -25,000 and a net result of DKK 242,298 compared with DKK 224,787 the year before. Equity in the 2022 report amounted to DKK 831,783. The solvency ratio was 92.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK -25,000
- Profit/Loss
- DKK 242,298
- Equity
- DKK 831,783
- Total Assets
- DKK 896,103
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -25 t. | 242 t. | 832 t. | - |
| 2021 | 0 | -24 t. | 225 t. | 589 t. | - |
| 2020 | 0 | -23 t. | 158 t. | 749 t. | - |
| 2019 | - | -23 t. | 379 t. | 5.6 mio. | - |
| 2018 | - | -31 t. | 409 t. | 5.2 mio. | - |
Official annual report
Keep an eye on PHARMATEKET ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMATEKET ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 224,787.
About PHARMATEKET ApS
PHARMATEKET ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1991. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Eli Wallin and Michael Maul Svarrer. The company is owned by PHARMA NORD EXPORT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,250 and a net result of DKK 197,932 compared with DKK 345,812 the year before. Equity in the 2025 report amounted to DKK 1,432,509.